Amoeba SA ALMIB

Basel, Switzerland and Chassieu, France, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market launches from 2028/29; This new-generation biocontrol fungicide, developed from Amoéba's solution, is designed to control septoria tritici blotch and yellow rust, two major fungal diseases affecting wheat, and other cereal diseases while helping to limit the development of resista

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained marketing authorization for its biofungicide AXPERA in France. This first authorisation, granted by ANSES following the evaluation conducted by France in its capacity as rapporteur Member State for European Union, now allows the other concerned Member States concerned to proceed with and finalise their

Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba receives its first order from Koppert and confirms its transformation into a commercial company Chassieu (France), 11 March 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces its first order from its partner Koppert, world leader in biocontrol. Amoéba thus becomes a true commercial company, whose biocontrol activ

Chassieu, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The ANSES evaluation process for the application submitted in March 2025 is currently in its final stage.At the same time, French and Italian agricultural sectors have begun procedures to obtain derogatory marketing authorisations for the use of AXPERA to combat fungal diseases from the start of their production season.At this stage, there is nothing to prevent the marketing authorisation of the product in 2026. Chassieu (France), 23 February 2026 – 6: